Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
about
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era.
P2860
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@en
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@nl
type
label
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@en
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@nl
prefLabel
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@en
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@nl
P2093
P2860
P1433
P1476
Intrathecal methotrexate proph ...... n, vincristine and prednisone.
@en
P2093
Ayumi Numata
Chizuko Hashimoto
Daisuke Ishibashi
Hirotaka Takasaki
Jun Taguchi
Katsumichi Fujimaki
Kumiko Kishimoto
Maki Hagihara
Naoto Tomita
Reina Watanabe
P2860
P304
P356
10.3109/10428194.2014.931953
P577
2014-08-06T00:00:00Z